“um but a lot of capital. So ah what happened was they started to look at um opportunities to invest that capital into related companies so that they could find a path forward for second-site medical products. We were one of the companies that they were evaluating in part because some of the directors of Nano Precision Medical were also directors of second-site medical products.”